| Literature DB >> 35529803 |
Zahra Nabizadeh1,2, Mahmoud Nasrollahzadeh3, Hamed Daemi4, Mohamadreza Baghaban Eslaminejad5, Ali Akbar Shabani1,2, Mehdi Dadashpour1,2, Majid Mirmohammadkhani6, Davood Nasrabadi1,2.
Abstract
Osteoarthritis, which typically arises from aging, traumatic injury, or obesity, is the most common form of arthritis, which usually leads to malfunction of the joints and requires medical interventions due to the poor self-healing capacity of articular cartilage. However, currently used medical treatment modalities have reported, at least in part, disappointing and frustrating results for patients with osteoarthritis. Recent progress in the design and fabrication of tissue-engineered microscale/nanoscale platforms, which arises from the convergence of stem cell research and nanotechnology methods, has shown promising results in the administration of new and efficient options for treating osteochondral lesions. This paper presents an overview of the recent advances in osteochondral tissue engineering resulting from the application of micro- and nanotechnology approaches in the structure of biomaterials, including biological and microscale/nanoscale topographical cues, microspheres, nanoparticles, nanofibers, and nanotubes.Entities:
Keywords: biological cues; cartilage regeneration; micro/nanotopographical cues; nanotechnology; osteoarthritis; regenerative medicine
Year: 2022 PMID: 35529803 PMCID: PMC9039523 DOI: 10.3762/bjnano.13.31
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.272
Figure 1A schematic representation of the issues covered in this review.
Figure 2Simplified graphical representation of a cross section of articular cartilage and its associated molecular components. Articular cartilage is normally divided into four distinct regions (the superficial, middle, deep, and calcified zones) visually characterized by the orientation of the collagen fibrils and chondrocyte morphology.
Summary of the factors influencing cell fate that should be taken into account when designing a scaffold.
| Factors | Example | Effects/applications | Important notes | Ref. |
|
|
||||
| Biological cues | Full-length proteins, cell adhesion motifs, HA binding domain, ECM constituents, etc. | Biological cues provide a desirable microenvironment for cell attachment, spread, migration, proliferation, and differentiation. |
The composition of the MSC-derived ECM greatly depends on the stage of the chondrogenic differentiation of MSCs. |
[ |
| Surface chemistry | — | Surface chemistry plays an important role in cell adhesion, proliferation, and morphology. |
— | [ |
| Geometry | Curvature, porosity, pore size, and pore shape. | Scaffold geometry plays a key role in chondrocyte adhesion and regulates their phenotype and function. |
While other parameters of the porous structure are fixed, the change in pore size often leads to a change in the mechanical properties of the porous scaffold. | [ |
| Microtopography | Microgrooves, microgrids, microholes, and micropillars. | Cell structure, morphology, and migration are affected by microtopography. |
The size of the ridges plays a more important role than the grooves in determining the MSC fate. |
[ |
| Nano-topography | Nanogrooves, nanogrids, nanoholes, and nanopillars. | Nanopatterned surfaces can induce and enhance receptor-mediated cellular responses. |
The nanoscale topography alone cannot significantly improve the chondrogenic differentiation and its impact depends on surface chemistry. | [ |
| Surface stiffness | Surface stiffness arises from substrate chemistry and controls stem cell differentiation. |
There is no widely accepted value for stiffness modulus that specifically determines the fate of stem cells. | [ |
|
Summary of the recent studies on microscale/nanoscale materials used for the fabrication of cartilage tissue engineering (TE) structures.
| Microscale/ nanoscale material type | Microscale/ nanoscale material application | Base material | Scaffold used | Cell type | In vivo | Major result | Ref. |
|
|
|||||||
| Microspheres | The increase in the proliferation rate of MSCs and their chondrogenic differentiation. | Gelatin | Gelatin microsphere | Human BMSCs | — | Culturing MSCs on gelatin microspheres accelerated proliferation rate and preserved stemness properties as well as enhanced chondrogenesis | [ |
| Microspheres | Delivery of rapamycin | PLGA | — | Human chondrocytes | Mice model | Provided sustained and controlled release of rapamycin for several weeks and prevented OA-like changes in chondrocytes under genomic and oxidative stress conditions | [ |
| Microspheres | Verteporfin delivery | Chitosan | Collagen I-coated culture dish and PDMS substrates | Human chondrocytes | Mice model | Provided a local sustained release of verteporfin and significantly maintained cartilage homeostasis in a mice OA model | [ |
| Microspheres | Microencapsulation of human osteoarthritic chondrocytes (hOACs) | Collagen | Collagen scaffold | hOACs | — | Collagen microspheres, as a screening platform, better maintained the hOAC phenotype compared with the 2D monolayer and 3D pellet cultures | [ |
| Microspheres | As a scaffold | Cartilage | Cartilage microspheres | Rabbit MSCs | — | Induced the in vitro chondrogenesis without adding any serum or induction components | [ |
| Nanocapsules | Celecoxib delivery | HA | — | — | Rat model | Spherical shape, high entrapment efficiency (97.98%), prolonged drug release, and improved histopathology analysis | [ |
| NPs | Delivery of SM | PLGA | — | — | Rat model | Increased the chondroprotective effects of SM | [ |
| NPs | KGN delivery | PLGA | m-HA | — | Porcine model | Improved hyaline cartilage and subchondral bone repair and demonstrated better therapeutic efficacy in full-thickness chondral defects | [ |
| NPs | Melatonin delivery | Albumin | PCL scaffold | Human chondrocytes | — | Prolonged the drug release for 22 days and increased GAG deposition | [ |
| Nanotubes | Cartilage repair | Carboxylated SWCNTs | SWCNTs/BSA/collagen composite scaffold | BMSCs | Rabbit model | Had no cytotoxic effect on BMSCs, improved mechanical properties and cell proliferation, and repaired cartilage defects in a rabbit model | [ |
| Electrospun nanofibers | Scaffold fabrication | ECM/PCL hybrid | Cartilage-derived ECM/PCL composite | Rabbit chondrocyte | Mice model | Considerably promoted the proliferation of chondrocytes in vitro and facilitated the regeneration of cartilage in vivo | [ |
| Electrospun nanofibers | Fabrication of a biocompatible scaffold | PLA/gelatin | CS-modified nanofibers | Rabbit BMSCs | Rabbit model | Had appropriate mechanical properties and suitable biocompatibility, showed better chondrogenic differentiation and promoted cartilage regeneration | [ |
| Electrospun nanofibers | Fabrication of scaffold | PLLA | The PLLA/PDA/CS membranes | Rabbit chondrocytes/rabbit BMSCs | Rabbit model | Considerably facilitated the filling of the defect site and the generation of hyaline-like cartilage in vivo | [ |
| Electrospun nanofibers | Scaffold fabrication | PCL/PEO | PCL/PEO combined with MSCs-derived TE construct | Rabbit synovial stem cells | Rabbit model | Significantly prevented meniscal extrusion, exerted a chondroprotective effect, and repaired meniscal defects | [ |
| Nanocapsules | Delivery of TGF-β1 | Gelatin and iron oxide | — | ATDC5 cells | — | Magnetic gelatin nanocapsules improved the differentiation of ATDC 5 cells with the increased expression of Col2a1 and aggrecan | [ |
| Nanocrystal– polymer particles | Delivery of p38α/β MAPK inhibitor | PLA | — | Human OA synoviocytes | Mice model | Were non-toxic to cultured human OA synoviocytes, exhibited good retention in the joint and adjacent tissues, and also decreased inflammation and joint degradation | [ |
| Nanofibers | Fabrication of collagen-like nanorods | Chitosan and polydiisopropyl fumarate | Fumarate copolymer– chitosan crosslinked nanofibers | Rat BMPCs/rat chondrocytes | — | Supported cell attachment and growth, as well as promoted both osteogenic and chondrogenic differentiation | [ |
| NPs | Delivery of curcuminoid | HA/chitosan | — | Rat chondrocytes | Rat model | Provided prolonged release of curcuminoid, inhibited NF-kB signaling and the expression of MMP-1 and MMP-13, and upregulated the expression of type-II collagen in chondrocytes in vitro, as well as reduced the Outerbridge classification and Mankin pathological scores in a knee OA model | [ |
| Nanogels | Encapsulation of TGF-β3 | Alginate | — | hMSCs | — | Significantly reduced burst release, provided the sustained release of TGF-β3, and also resulted in better chondrogenic differentiation of hMSCs | [ |
| Nano- composites | Fabrication of scaffold | PLDLA/HAp | PLDLA/HAp enriched with sodium alginate | — | Rabbit model | Improvement in articular cartilage defect treatment | [ |
| Dendrimer | Delivery of KGN | PEGylated PAMAM | — | BMSCs | Rat model | KGN-PEG-PAMAM conjugate could induce higher expression of chondrogenic markers | [ |
| NPs | Providing high RGD surface density | Gold | — | hMSCs | — | Had a promotive effect on cartilaginous matrix production and marker gene expression | [ |
| Dendrimers | Providing a surface for cell attachment | PAMAM | A PAMAM surface with fifth-generation (G5) dendron structure. | hMSCs | — | Affected the expression of type-II and type-X collagens via effects on cell aggregate behavior | [ |
| Magnetic NPs | Labeling of chondrocytes | Iron oxide | Collagen-chitosan/PLGA | Rabbit chondrocytes | — | Magnetic nanoparticles did not affect the cell phenotype and provided a technique for tracking cartilage regeneration and osteochondral defect repair | [ |
| Nanofibers | Fabrication of nanofiber-based scaffold | PLGA | PLGA | hMSCs | — | Induced MSC differentiation into bone and cartilage | [ |
| Nanofibers | Fabrication of scaffold | PLLA-PCL- collagen | PLLA-PCL- collagen/HA | Rabbit MSCs | — | Promoted orientation, adhesion and proliferation of BMSCs as well as expression of chondrogenic markers | [ |
| Magnetic NPs | Physical stimuli | Magnetic NPs isolated from Magneto- spirillm sp. | Micromass culture system used | hMSCs | — | Enhanced the level of sulfated glycosaminoglycan (GAG) and collagen synthesis,and facilitated chondrogenic differentiation | [ |
| NPs | KGN delivery | Chitosan | — | hMSCs | Rat model | Provided the sustained release of KGN and induced higher expression of chondrogenic markers | [ |
| NPs | Co-delivery of Cbfa-1-targeting siRNA and SOX9 protein | PLGA | — | hMSCs | Mice model | Highly expressed chondrogenesis-related extracellular matrix (ECM) components | [ |
| Nanofibers | Fabrication of electrospun embedded nanocomposite. | PLLA | PEG-POSS/PLLA | hMSCs | — | hMSCs were able to attach, proliferate, and differentiate into chondrocytes | [ |
| NPs | Delivery of pDC316-BMP4-EGFP Plasmid | PLGA | PLLGA | Rabbit ADSCs | Rabbit model | BMP-4 plasmid could be successfully delivered into ADSCs by PLGA nanoparticles and promoted in vitro and in vivo chondrogenesis | [ |
| Electrospun nanofibers | Fabrication of scaffold. | PCL | PCL | Human MenSCs | — | Induced chondrogenic differentiation of menstrual blood derived stem cells | [ |
| NPs | TGF-β1 gene delivery. | Calcium phosphate | Collagen/chitosan | Rat MSCs | — | Could successfully induce MSC chondrogenic differentiation | [ |
| Nanotubes | Providing titanium dioxide (TiO2) based surface. | TiO2 | TiO2 nanotube | Limb mesenchymal cells | — | Could support chondrocytic functions | [ |
| Nanofibers | Fabrication of scaffold. | PLLA | PLLA | hMSCs | — | Expressed cartilage-specific gene and formed typical cartilage morphology | [ |
| Nanofibers | As scaffold | PCL | PCL | hMSCs/pig chondrocyte | Swine model | Showed the most complete repair, generated hyaline-like cartilage tissue, and had the highest equilibrium compressive stress (1.5 MPa) in the regenerated cartilage | [ |
Figure 3(Top) SEM images of electrospun nanofibers, representing the soft group (35% modified MeHA) and the stiff group (100% modified MeHA). (Bottom) Gene expression analysis of chondrogenic markers of hMSCs seeded on these scaffolds. RGD peptides in different concentrations were also used to enhance scaffold adhesivity. Figure 3 was reprinted from [8], Biomaterials, vol. 34, by I. L. Kim; S. Khetan; B. M. Baker; C. S. Chen; J. A. Burdick, “Fibrous hyaluronic acid hydrogels that direct MSC chondrogenesis through mechanical and adhesive cues”, pages 5571–5580, Copyright (2013), with permission from Elsevier. This content is not subject to CC BY 4.0.
Figure 4Schematic representation of GelMA-coated CNTs embedded in gelatin hydrogel for the preparation of the engineered cardiac tissue. Confocal images revealed that cardiomyocytes cultured on 1 mg/mL CNT-GelMA hydrogel had a more uniform cell distribution relative to cells cultured on control GelMA hydrogel. Schematic representation of a tubular actuator and its beating direction (red arrow) in addition to an optical image of a sample. Figure 4 was reprinted with permission from [132], Copyright (2013) American Chemical Society. This content is not subject to CC BY 4.0.